Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride for Arterial Stiffness in Insulin Resistant Subjects
NCT03837626Phase 3Completed
- Sponsor
- University of Missouri
- Start
- Jul 2019
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity and insulin resistance (IR) comparing Placebo with Amiloride (2 arms). Primary endpoint: Carotid Femoral Pulse Wave Velocity at 6 months. Started Jul 2019; status: completed.
02
Drugs
amiloride
03
Conditions
obesityinsulin resistance (IR)
Beyond the preview
Go deeper on NCT03837626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03837626.